Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Director comp.
|
|
MoonLake Immunotherapeutics
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/10/2023 |
8-K
| Quarterly results |
| 06/29/2023 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data |
| 06/07/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/19/2023 |
8-K
| Quarterly results |
| 03/20/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 06/17/2022 |
8-K
| Quarterly results |
| 06/07/2022 |
8-K
| Quarterly results |
| 05/16/2022 |
8-K/A
| Quarterly results |
| 04/11/2022 |
8-K
| Amended existing or entered into new employment agreement with an officer, Director compensation was amended/approved|
Docs:
|
"Memorandum and Articles of Association of MoonLake Immunotherapeutics",
"Amended and Restated Shareholders’ Agreement, by and among MoonLake Immunotherapeutics, MoonLake Immunotherapeutics AG and the investors signatory thereto",
"Amended and Restated Registration Rights Agreement, by and among the MoonLake Immunotherapeutics, Helix Holdings LLC and the holders signatory thereto",
"Form of Subscription Agreement",
"MOONLAKE IMMUNOTHERAPEUTICS 2022 EQUITY INCENTIVE PLAN",
"Letter Agreement, among Helix Acquisition Corp., Helix Holdings LLC and each of the officers and directors of Helix (incorporated by reference to of Helix’s Form 8-K, filed with the SEC on October 22, 2020)",
"Code of Business Conduct and Ethics",
"Subsidiaries of MoonLake Immunotherapeutics",
"MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.",
"MoonLake Immunotherapeutics unaudited pro forma condensed combined balance sheet as of December 31, 2021 and the unaudited pro forma condensed combined statement of operations for the year ended December 31, 2021" |
|
| 03/31/2022 |
8-K
| Quarterly results |
| 03/24/2022 |
8-K
| Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ... |
| 02/25/2022 |
8-K
| Quarterly results |
| 12/03/2021 |
8-K
| Quarterly results |
| 10/04/2021 |
8-K
| Quarterly results |
| 05/03/2021 |
8-K
| Quarterly results |
| 02/24/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events |
| 10/28/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 10/22/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Departure of Directors or Certain Office...|
Docs:
|
"Underwriting Agreement, between the Company and Jefferies LLC",
"Amended and Restated Memorandum and Articles of Association",
"Letter Agreement, among the Company, Helix Holdings LLC and each of the officers and directors of the Company",
"Investment Management Trust Agreement, between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, among the Company, Helix Holdings LLC and the Holders signatory thereto",
"Private Placement Class A Ordinary Shares Purchase Agreement, between the Company and Helix Holdings LLC",
"Administrative Services Agreement, between the Company and Helix Holdings LLC",
"Press Release",
"EXHIBIT 99.2 Helix Acquisition Corp. Announces Closing of $115 Million Initial Public Offering, Including the Full Exercise of the Underwriter’ s Option to Purchase Additional Shares" |
|
|
|